Literature DB >> 21356422

Prescription drug abuse: epidemiology, regulatory issues, chronic pain management with narcotic analgesics.

Jeanne M Manubay1, Carrie Muchow2, Maria A Sullivan3.   

Abstract

The epidemic of prescription drug abuse has reached a critical level, which has received national attention. This article provides insight into the epidemiology of prescription drug abuse, explains regulatory issues, and provides guidelines for the assessment and management of pain, particularly with long-term opioid therapy. Using informed consent forms, treatment agreements, and risk documentation tools and regularly monitoring the 4 A's help to educate patients and guide management based on treatment goals. By using universal precautions, and being aware of aberrant behaviors, physicians may feel more confident in identifying and addressing problematic behaviors.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21356422      PMCID: PMC3328297          DOI: 10.1016/j.pop.2010.11.006

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  31 in total

Review 1.  Definitions related to the medical use of opioids: evolution towards universal agreement.

Authors:  Seddon R Savage; David E Joranson; Edward C Covington; Sidney H Schnoll; Howard A Heit; Aaron M Gilson
Journal:  J Pain Symptom Manage       Date:  2003-07       Impact factor: 3.612

2.  The influence of prescription monitoring programs on chronic pain management.

Authors:  Jing Wang; Paul J Christo
Journal:  Pain Physician       Date:  2009 May-Jun       Impact factor: 4.965

3.  Chronic pain prevalence and analgesic prescribing in a general medical population.

Authors:  J David Clark
Journal:  J Pain Symptom Manage       Date:  2002-02       Impact factor: 3.612

4.  Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history.

Authors:  Edward Michna; Edgar L Ross; Wilfred L Hynes; Srdjan S Nedeljkovic; Sharonah Soumekh; David Janfaza; Diane Palombi; Robert N Jamison
Journal:  J Pain Symptom Manage       Date:  2004-09       Impact factor: 3.612

Review 5.  2009 Clinical Guidelines from the American Pain Society and the American Academy of Pain Medicine on the use of chronic opioid therapy in chronic noncancer pain: what are the key messages for clinical practice?

Authors:  Roger Chou
Journal:  Pol Arch Med Wewn       Date:  2009 Jul-Aug

6.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Authors:  Roger Chou; Gilbert J Fanciullo; Perry G Fine; Jeremy A Adler; Jane C Ballantyne; Pamela Davies; Marilee I Donovan; David A Fishbain; Kathy M Foley; Jeffrey Fudin; Aaron M Gilson; Alexander Kelter; Alexander Mauskop; Patrick G O'Connor; Steven D Passik; Gavril W Pasternak; Russell K Portenoy; Ben A Rich; Richard G Roberts; Knox H Todd; Christine Miaskowski
Journal:  J Pain       Date:  2009-02       Impact factor: 5.820

7.  Medical use, illicit use, and diversion of abusable prescription drugs.

Authors:  Sean Esteban McCabe; Christian J Teter; Carol J Boyd
Journal:  J Am Coll Health       Date:  2006 Mar-Apr

8.  Development and validation of the Current Opioid Misuse Measure.

Authors:  Stephen F Butler; Simon H Budman; Kathrine C Fernandez; Brian Houle; Christine Benoit; Nathaniel Katz; Robert N Jamison
Journal:  Pain       Date:  2007-05-09       Impact factor: 6.961

Review 9.  Are opioid-dependent/tolerant patients impaired in driving-related skills? A structured evidence-based review.

Authors:  David A Fishbain; R Brian Cutler; Hubert L Rosomoff; Renee Steele Rosomoff
Journal:  J Pain Symptom Manage       Date:  2003-06       Impact factor: 3.612

10.  Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the International Association for the Study of Pain, Subcommittee on Taxonomy.

Authors: 
Journal:  Pain Suppl       Date:  1986
View more
  15 in total

1.  Opioids induce dissociable forms of long-term depression of excitatory inputs to the dorsal striatum.

Authors:  Brady K Atwood; David A Kupferschmidt; David M Lovinger
Journal:  Nat Neurosci       Date:  2014-02-23       Impact factor: 24.884

Review 2.  Opioid misuse in gastroenterology and non-opioid management of abdominal pain.

Authors:  Eva Szigethy; Mitchell Knisely; Douglas Drossman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-11-15       Impact factor: 46.802

3.  Comparison of a drug versus money and drug versus drug self-administration choice procedure with oxycodone and morphine in opioid addicts.

Authors:  Sandra D Comer; Verena E Metz; Ziva D Cooper; William J Kowalczyk; Jermaine D Jones; Maria A Sullivan; Jeanne M Manubay; Suzanne K Vosburg; Mary E Smith; Deena Peyser; Phillip A Saccone
Journal:  Behav Pharmacol       Date:  2013-09       Impact factor: 2.293

4.  Medicaid trends in prescription opioid and non-opioid use by HIV status.

Authors:  Chelsea Canan; G Caleb Alexander; Richard Moore; Irene Murimi; Geetanjali Chander; Bryan Lau
Journal:  Drug Alcohol Depend       Date:  2019-02-13       Impact factor: 4.492

Review 5.  Do initial responses to drugs predict future use or abuse?

Authors:  Harriet de Wit; Tamara J Phillips
Journal:  Neurosci Biobehav Rev       Date:  2012-04-21       Impact factor: 8.989

6.  Low dispositional mindfulness predicts self-medication of negative emotion with prescription opioids.

Authors:  Eric L Garland; Adam W Hanley; Elizabeth A Thomas; Paul Knoll; Jeffrey Ferraro
Journal:  J Addict Med       Date:  2015 Jan-Feb       Impact factor: 3.702

7.  Hair drug testing results and self-reported drug use among primary care patients with moderate-risk illicit drug use.

Authors:  Jan Gryczynski; Robert P Schwartz; Shannon Gwin Mitchell; Kevin E O'Grady; Steven J Ondersma
Journal:  Drug Alcohol Depend       Date:  2014-05-17       Impact factor: 4.492

8.  Electronic Health Record-Based Screening for Substance Abuse.

Authors:  Farrokh Alemi; Sanja Avramovic; Mark D Schwartz
Journal:  Big Data       Date:  2018-09-19       Impact factor: 2.128

Review 9.  The downward spiral of chronic pain, prescription opioid misuse, and addiction: cognitive, affective, and neuropsychopharmacologic pathways.

Authors:  Eric L Garland; Brett Froeliger; Fadel Zeidan; Kaitlyn Partin; Matthew O Howard
Journal:  Neurosci Biobehav Rev       Date:  2013-08-26       Impact factor: 8.989

Review 10.  Treating Diabetic Neuropathy: Present Strategies and Emerging Solutions.

Authors:  Saad Javed; Uazman Alam; Rayaz A Malik
Journal:  Rev Diabet Stud       Date:  2015-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.